6 results
An evidence-based algorithm to guide the use of MRSA coverage (in community acquired pneumonia) is shown
the use of MRSA coverage ... (in community acquired ... Pneumonia #Algorithm #CAP ... #Community #Acquired ... Management #Deescalate #Deescalation
Antibiotics for severe community-onset pneumonia 

Atypical coverage always 

- Usually azithromycin 500 mg daily 

- Doxycycline
Antibiotics for severe community-onset ... pneumonia Atypical coverage ... ) MRSA coverage ... Vancomycin #Community ... Acquired #Pneumonia #CAP
Antiplatelet Conversion - Switching Between P2Y12 Inhibitors
Oral P2Y12 inhibitors vary in potency and pharmacokinetic and dynamic
Antiplatelet Conversion ... P2Y12 inhibitors can ... P2Y12 inhibitors can ... Inhibitors - Escalation ... Inhibitor #switching #conversion
Community Acquired Pneumonia (CAP) - Diagnosis and Management

Pneumonia Signs/Symptoms:
 • Confusion/disorientation (LR + 1.9)
 • Cough
Community Acquired ... Pneumonia (CAP) ... MRSA: Add MRSA coverage ... Aeruginosa: Add coverage ... treatment #Pulmonary #Community
Antiplatelet Conversion - Switching Between Oral P2Y12 Inhibitors
A, Switching between oral agents in the acute/early phase.
Antiplatelet Conversion ... patients who are deescalating ... ), when the LD can ... De-escalation from ... Inhibitor #switching #conversion
For my UME micro course, I made a figure that captures this terminology and lets learners
‘broaden’ this coverage ... ” and “de-escalation ... holes” in their coverage ... We can combine these ... #antibiotics #coverage